Summary Safety Review - Fluoroquinolones - Assessing the potential risk of persistent and disabling side effects (French, HTML)
Summary Safety Review - Fluoroquinolones - Assessing the potential risk of persistent and disabling side effects: French HTML file. From Health Canada, updated May 2024. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2024-05-09
Health Canada started a safety review following a review done by the FDA on systemic (taken by mouth or by injection) fluoroquinolone drugs. The FDA review showed that there were persistent (lasting 30 days or longer after stopping use of fluoroquinolones) and disabling side effects linked to the use of fluoroquinolone products.
Data overview
- Formats
- HTML
- File languages
- French
- Available actions
- Access original file